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SUMMARY The diagnostic value of measuring a gliadin antibodies in children with suspected coeliac disease has been evaluated prospectively. Jejunal biopsy and a gliadin antibody measurements were performed in 77 consecutive children who were being investigated for a suspected malabsorption syndrome. The typical small intestinal histological lesion of coeliac disease was found, and this diagnosis was subsequently confirmed clinically in 20 children. Raised IgG a gliadin antibody concentrations were found in 19 (95%). Fifty of 57 patients (88%) with a normal jejunal mucosa had normal a gliadin antibody concentrations. These results are similar to those previously reported in a prospective study of was not significant, however, and although four of the patients with coeliac disease had raised titres, four of the controls who were being investigated for gastrointestinal symptoms also had raised antibody concentrations. No difference was seen between the IgG concentrations to soya protein extract in either the group with coeliac disease or the control group.
Detection of specific IgA antibodies to 13 lactoglobulin and soya protein antigens showed no difference in the response of the untreated children with coeliac disease and the controls.
Discussion
This prospective study shows the diagnostic value of measuring a gliadin antibody in children with symptoms of malabsorption and in whom coeliac disease is suspected. When 77 consecutive children were investigated 20 had the typical small intestinal i histological lesion of coeliac disease, 19 of whom had raised IgG a gliadin antibody concentrations, whereas 50 of the 57 children with normal small I intestinal histology had normal antibody concentrations. All of the 20 children with the coeliac lesion showed improvement clinically on gluten free diet, and the 10 children who were subsequently challenged with gluten showed a clinical relapse, which was histologically confirmed on further biopsy I examination. This gave the test a sensitivity of 95% and specificity of 88%, and these values agree well with our previous prospective study of adults with 0 I suspected coeliac disease.4 The results also confirm the findings of Burgin-Wolff et al, who described the only other study in which measurement of wheat protein antibodies was prospectively evaluated as a screening test in childhood coeliac disease.7 They employed gliadin as antigen in a fluorescence assay system and found raised antibody concentrations in all their patients with coeliac disease and in 16% of those without coeliac disease. The two studies further concur in that measurement of IgG class antibodies was most informative and that antibody concentrations to other dietary antigens were of no diagnostic help.
In previous non-prospective studies of coeliac disease an increased incidence of IgG antibodies to wheat protein antigens was shown. i" As wheat protein antibodies were also found in other diseases, however, these assays could not be relied on to discriminate consistently between patients with coeliac disease and those without. Consequently, many investigators have recommended the measurement of IgA wheat protein antibodies."' 3 Although the finding of wheat protein antibodies of IgA class is generally quite specific for the diagnosis of coeliac disease, several reports show this to be an insensitive test, especially in older children and adults.|" " 13 In this study, although IgA a gliadin antibodies were found in fewer of the patients without coeliac disease, raised concentrations were detected in only five of the 12 serum samples of patients with coeliac disease, rendering the detection of IgA a gliadin antibodies unsuitable as a screening test.
The antigen used in our assay was a gliadin. There is evidence that the major cellular and humoral immune response in patients with coeliac disease is directed towards this particular subfraction of gliadin3 14 I' and that it is more toxic to coeliac jejunal tissue than other wheat protein fractions."" Unfractionated gliadin used in this ELISA system did not discriminate adequately between patients with and without coeliac disease.4 As unfractionated gliadin was used in previous studies this may explain the difficulties experienced in differentiating the patient group from the control group,8 '13 although in some assays gliadin can be a satisfactory test antigen.7
To determine the effect of age on a gliadin antibody responses, samples from normal control children aged 1 to 15 years were evaluated. A gradual increase in both IgG and IgA a gliadin antibody concentrations was found that paralleled the age related increase in total immunoglobulin concentrations. The use of age matched controls was not necessary when screening for coeliac disease, however, as the titres obtained from the children with coeliac disease exceeded even the normal adult values. Raised antibody concentrations were found in seven of the control subjects. Of these, one patient had cystic fibrosis, two had a strong family history of coeliac disease, one had cow's milk protein intolerance, one was less than the 25th weight and 50th height centiles and had diarrhoea, and the remaining two had persistent diarrhoea. It has been documented that patients with coeliac disease vary in their sensitivity to gluten and may require a high gluten intake for several months before showing histological changes. '9 Gluten challenge might therefore induce the characteristic lesion of coeliac disease in some of this group with raised a gliadin antibody concentrations.
Screening tests for coeliac disease, including measurement of faecal fat, measurement of D-xylose absorption, radiological examination of the small bowel, haematological investigations, and detection of reticulin antibodies have been used in the past. None of these investigations is regarded as adequately sensitive or specific for coeliac disease.2022
In contrast, our study shows that as only one patient with true coeliac disease had normal antibody concentrations measurement of a gliadin antibody using ELISA in children with suspected coeliac disease is a highly sensitive test. As this test is simple and cheap to perform it is useful for screening patients before performing the ultimate investigation-that is, small intestinal biopsy. The assay may also help to distinguish patients likely to respond to gluten withdrawal from those with other malabsorptive diseases. Finally, as gluten withdrawal is accompanied by a fall in antibody concentrations4 7 a gliadin antibody measurement may be used to monitor dietary compliance.
